Specific Aspects of Immunotherapy for Multiple Sclerosis in Switzerland: A Structured Commentary

Clinical and Translational Neuroscience
doi 10.1177/2514183x18822073
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Virus Specific Antibodies in Multiple Sclerosis.

BMJ
1972English

Perspectives of People With Multiple Sclerosis About Helminth Immunotherapy

International Journal of MS Care
NeurologySpecialized NursingAdvanced
2020English

BOOK REVIEWS: Neurobehavioral Aspects of Multiple Sclerosis.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1991English

New Insights Into the Burden and Costs of Multiple Sclerosis in Europe: Results for Switzerland

Multiple Sclerosis
Neurology
2017English

T-Cell Based Immunotherapy in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis

Immunotherapy
OncologyAllergyImmunology
2010English

Adoptive Transfer of Regulatory T Cells as a Promising Immunotherapy for the Treatment of Multiple Sclerosis

Frontiers in Neuroscience
Neuroscience
2019English

Rehabilitation in Multiple Sclerosis: Commentary on the Recent AAN Systematic Review

Neurology: Clinical Practice
Neurology
2017English

G1m1 Predominance of Intrathecal Virus-Specific Antibodies in Multiple Sclerosis

Annals of Clinical and Translational Neurology
NeuroscienceNeurology
2018English

No Evidence for Association of a European-Specific Chromosome 17 Inversion With Multiple Sclerosis

European Journal of Human Genetics
Genetics
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy